CN103892280A - 天然食物元素强化剂酵素西瓜粉 - Google Patents
天然食物元素强化剂酵素西瓜粉 Download PDFInfo
- Publication number
- CN103892280A CN103892280A CN201410112395.4A CN201410112395A CN103892280A CN 103892280 A CN103892280 A CN 103892280A CN 201410112395 A CN201410112395 A CN 201410112395A CN 103892280 A CN103892280 A CN 103892280A
- Authority
- CN
- China
- Prior art keywords
- natural food
- natural
- watermelon
- zinc
- strengthening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 64
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 title claims abstract description 27
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 17
- 239000000843 powder Substances 0.000 title claims abstract description 14
- 241000219109 Citrullus Species 0.000 title abstract description 25
- 239000003623 enhancer Substances 0.000 title abstract 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229930003231 vitamin Natural products 0.000 claims abstract description 33
- 235000013343 vitamin Nutrition 0.000 claims abstract description 33
- 239000011782 vitamin Substances 0.000 claims abstract description 33
- 229940088594 vitamin Drugs 0.000 claims abstract description 33
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011701 zinc Substances 0.000 claims abstract description 25
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 25
- 239000000284 extract Substances 0.000 claims abstract description 22
- 229910052742 iron Inorganic materials 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 19
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 15
- 239000011669 selenium Substances 0.000 claims abstract description 15
- 241000196324 Embryophyta Species 0.000 claims abstract description 12
- 229910052793 cadmium Inorganic materials 0.000 claims abstract description 12
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052802 copper Inorganic materials 0.000 claims abstract description 11
- 239000010949 copper Substances 0.000 claims abstract description 11
- 239000011737 fluorine Substances 0.000 claims abstract description 9
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 6
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052753 mercury Inorganic materials 0.000 claims abstract description 4
- 239000011858 nanopowder Substances 0.000 claims description 30
- 238000005728 strengthening Methods 0.000 claims description 30
- 239000013589 supplement Substances 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 15
- 229910052748 manganese Inorganic materials 0.000 claims description 15
- 239000011572 manganese Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 13
- 238000007599 discharging Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 10
- 229910052804 chromium Inorganic materials 0.000 claims description 10
- 239000011651 chromium Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 8
- 206010020772 Hypertension Diseases 0.000 claims description 8
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 7
- 230000001934 delay Effects 0.000 claims description 7
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 241000222336 Ganoderma Species 0.000 claims description 6
- 241000251511 Holothuroidea Species 0.000 claims description 6
- 244000269722 Thea sinensis Species 0.000 claims description 6
- 210000002969 egg yolk Anatomy 0.000 claims description 6
- 238000006213 oxygenation reaction Methods 0.000 claims description 6
- 230000009469 supplementation Effects 0.000 claims description 5
- CTSSAYHSUGVGJN-UHFFFAOYSA-N [Ge].[Se][Pb] Chemical compound [Ge].[Se][Pb] CTSSAYHSUGVGJN-UHFFFAOYSA-N 0.000 claims description 4
- WPQVKKFPOFIUFF-UHFFFAOYSA-M fluorolead Chemical compound [Pb]F WPQVKKFPOFIUFF-UHFFFAOYSA-M 0.000 claims description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 241000272522 Anas Species 0.000 claims description 3
- 244000025352 Artocarpus heterophyllus Species 0.000 claims description 3
- 235000008725 Artocarpus heterophyllus Nutrition 0.000 claims description 3
- 241000208688 Eucommia Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 241000237858 Gastropoda Species 0.000 claims description 3
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 240000007049 Juglans regia Species 0.000 claims description 3
- 235000009496 Juglans regia Nutrition 0.000 claims description 3
- 244000241872 Lycium chinense Species 0.000 claims description 3
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 241000646357 Monopterus cuchia Species 0.000 claims description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 3
- 241000237502 Ostreidae Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 244000197580 Poria cocos Species 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- 240000001341 Reynoutria japonica Species 0.000 claims description 3
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 3
- 241001165494 Rhodiola Species 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- 235000006468 Thea sinensis Nutrition 0.000 claims description 3
- 235000020279 black tea Nutrition 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 235000013345 egg yolk Nutrition 0.000 claims description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 230000001473 noxious effect Effects 0.000 claims description 3
- 235000014571 nuts Nutrition 0.000 claims description 3
- 210000004681 ovum Anatomy 0.000 claims description 3
- 235000020636 oyster Nutrition 0.000 claims description 3
- 239000002699 waste material Substances 0.000 claims description 3
- 244000241235 Citrullus lanatus Species 0.000 claims 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 abstract description 10
- 235000013619 trace mineral Nutrition 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 7
- 229910052782 aluminium Inorganic materials 0.000 abstract description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract description 6
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 229910052732 germanium Inorganic materials 0.000 abstract description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241001464837 Viridiplantae Species 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 229910052785 arsenic Inorganic materials 0.000 abstract 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- 229940091258 selenium supplement Drugs 0.000 description 13
- 238000002156 mixing Methods 0.000 description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 235000001465 calcium Nutrition 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 239000011133 lead Substances 0.000 description 7
- 239000011574 phosphorus Substances 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 235000014786 phosphorus Nutrition 0.000 description 7
- 102000019197 Superoxide Dismutase Human genes 0.000 description 6
- 108010012715 Superoxide dismutase Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000003470 mitochondria Anatomy 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000004411 aluminium Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000206607 Porphyra umbilicalis Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000036905 Benincasa cerifera Species 0.000 description 2
- 235000011274 Benincasa cerifera Nutrition 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 241000255601 Drosophila melanogaster Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 244000081841 Malus domestica Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- -1 adjusting Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical group 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- XEABSBMNTNXEJM-UHFFFAOYSA-N propagermanium Chemical compound OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O XEABSBMNTNXEJM-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- XBBAEVVIDHSGKC-UHFFFAOYSA-N [As].[Hg] Chemical compound [As].[Hg] XBBAEVVIDHSGKC-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- OVFCVRIJCCDFNQ-UHFFFAOYSA-N carbonic acid;copper Chemical compound [Cu].OC(O)=O OVFCVRIJCCDFNQ-UHFFFAOYSA-N 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种天然食物元素强化剂酵素西瓜粉，是属于惠农科技天然食物元素保健食品配制生产技术领域。是强化微量元素、维生素族、微量元素天然绿色食物①-⑤号，降压降脂中药流浸膏，天然食物西瓜类提取物、植物酵素干燥纳米粉组成。以天然的高含锌、锰、铜、铁、硒、锗、氟等绿色食物以及能排镉、铅、汞、砷、铝的重金属元素和有毒有害物质的食物与营养最全面的丰富的西瓜为主的提取物植物酵素，组成天然食物元素强化剂，以日常自然的吃喝“药食同源”达到有效地调节、补充、拮抗体内元素平衡，延缓衰老，健康益寿。
Description
技术领域：
本发明公开了一种天然食物元素强化剂酵素西瓜粉，是属于惠农科技天然食物元素保健食品配制生产技术领域。
背景技术：
将某种或某几种微量元素有意识地加入到一定的食品中，以改善其营养水平，达到调节人体生理功能的目的，这就是食物的微量元素强化。而以人工合成的化合物形态直接加入到食物中，是应用最多的微量元素强化方法。如元素铁可用硫酸亚铁、乳酸亚铁、葡萄糖酸亚铁、柠檬酸铁、富马酸铁铵、柠檬酸铁铵等作强化剂；元素锌可用硫酸锌、乳酸锌、葡萄糖酸锌、氯化锌、氧化锌、醋酸锌等作强化剂；元素碘主要用碘化钾或碘酸钾强化剂；元素硒用亚硒酸钠、硒酸钠等作强化剂；元素铜以碳酸铜和硫酸铜作强化剂；元素锰用氧化锰和硫酸锰作强化剂；元素锗则常以羧乙基锗倍半氧化物(Ge-132)形式作强化剂。
由于天然食物西瓜中的微量元素含量一般都不高，以化合物形式研制的元素强化剂又常常引起胃肠不适，而且吸收利用率也偏低。因此，生物转化的办法就引起科研人员的普遍重视。微量元素的生物转化包括微生物合成转化法、植物天然合成转化法和动物转化法等。微生物合成转化法最常见的是酵母转化法，它是将含有一种或几种微量元素的溶液加入到培养基中，从而得到高富含微量元素的酵母。目前已研制成高锰、高锗、高锌、高铁、高硒等类型的酵母，应用于多种类型的保健食品饮料。
任何一种食物都含有几十种不同的元素，仅是含量高低不同，为了有效地补充天然绿色食物，含铁、锌、锰、硒、锗等且含量高有机态的自然食物，作为食物元素强化剂以日常自然的吃喝、药食同源，达到有效补充、调节、拮抗体内元素平衡，延缓衰老，健康益寿。
发明内容：
本发明的目的在于提供一种天然食物元素强化剂酵素西瓜粉。
本发明技术解决的方案是：
一种天然食物元素强化剂酵素西瓜粉，其特征是：由下列质量份配比组成％
(1)强化微量元素补充剂，其特征是：由下列单质态质量份配比组成％
(2)强化维生素族补充剂，其特征是：由下列质量成份配比组成％
维生素族是由水溶性维生素、脂溶性维生素组成；
水溶性维生素
脂溶性维生素
水溶性维生素95％+脂溶性维生素5％＝维生素族100％；
(3)强化补充微量元素天然绿色食物，其特征是：由下列质量份配比组成％
①补锌锰天然食物
含锌：牡蛎干每1000g含1210mg锌，田螺、海参占82mg，黄鳝140mg，菇类含锌80-140mg，含铁1885mg；
含锰：坚果、茶叶含锰每1000g含660-780mg，鸭蛋黄含2400mg，鸡蛋黄含1100mg；
②补铜排镉的天然食物
③补铁铬延缓衰老天然食物
黑木耳、干蘑菇每1000g含铁1850mg铁元素，海带1500mg，海参含铬21-38mg；
④补硒锗排铅增氧天然食物
胡桃每1000g含硒29.6mg，树菠萝27.9mg，灵芝、人参含硒、锗元素排铅、汞、碘、镉等重金属元素和有毒物质，增氧排废，抗氧化清除自由基；
⑤补氟排铅延缓衰老的天然食物
绿茶每1000g含氟89.4-220.4mg，红茶48.4±14.7mg；
(4)强化补充降压降脂益寿中药流浸膏，其特征是：由下列相同质量份配比组成％
灵芝、何首乌、枸杞子、茯苓、冬虫夏草、绞股蓝、红景天、黄芪、黄精、杜仲、当归、酸枣仁、蒲公英、松花粉；
功效：降血压、降血脂、调节免疫功能、延缓衰老；
应用：高血压、高血脂等中老年衰弱症；
实验研究：
①果蝇寿命试验：能显著延长雌雄果蝇平均寿命和最高寿命(♀P＜0.05，♂＜0.01)；
②小鼠试验：能使血清SOD活性显著升高(P＜0.01)，MDA含量显著降低(P＜0.01)；
③小鼠迟发变态反应试验：服药组与对照组比，足趾肿胀度均数有显著变异(P＜0.01)；血清溶血素试验，抗体积数有显著提高(P＜0.01)；腹腔巨噬细胞吞噬鸡红细胞试验，吞噬百分率，吞噬指数与对照组比，显著提高(P＜0.01)；NK细胞活性无显著差异(P＞0.05)，证明有免疫调节作用。
以上各组分别用常规二氧化碳萃取或用60％乙醇提取的方法提取，滤液经薄膜蒸发、回收乙醇，并浓缩成1∶1，即每毫升含源生药1g，相对密度为1.03-1.05的流浸膏备用。用时将流浸膏真空干燥研细与其他物料共同混合，将其混合物料再用纳米粒径超细微化通用装置将物料的大分子进行破碎、乳化、均质、分散，从而粒化成纳米级粒径的小分子过1800-2200目筛，中心粒径为0.1-5μm，因为药物的吸收常受药物在吸收部位溶出速度的支配，而减小粒径，可以增大在暴露在介质中的表面积，而促进溶解，进而提高药物的吸收度和利用率，增大了药效和治疗效果。
(5)强化补充天然食物西瓜类植物酵素干燥纳米粉，其特征是：由下列质量份配比组成％
黄豆芽有滋润清热利尿解毒之效，能减少体内乳酸堆积，治神经衰弱，消除疲劳，诱发干扰素，增强体内抗病毒，抗肿瘤，抗动脉硬化，防治老年高血压，是黄豆与水制成。黄豆是植物性高蛋白、高脂肪，“田中之肉”、“植物蛋白之王”、“绿色牛乳”之美称，含钙、磷、铁、锌等矿物元素。黄豆可以提高肌肤的新陈代谢，促使机体排毒，令肌肤常葆青春。
胡萝卜能增强人体免疫力、抗癌、保护多种脏器，防治血管硬化，降低胆固醇，防治高血压，清除致人衰老的自由基，滋润皮肤，抗衰老，促进儿童生长发育，增强机体抗病能力。胡萝卜含有丰富的维生素B1、B2、A、C、D、E、K、叶酸以及磷、钙，几乎可以与多种维生素药丸媲美，每500g胡萝卜含磷140g，钙305g。
冬瓜具有清热解暑，利尿通便，清热排毒，使皮肤白皙有光泽，可滋润皮肤，治雀斑，冬瓜含有维生素C、钙、磷、铁等。
常吃绿豆芽不仅减肥，清热解毒，利尿除湿，解酒毒、热毒，治疗口腔溃疡，调五脏，通经脉，治食少体倦，可防癌，疮疖，外伤感染，含丰富的维生素C、维生素B1、B2、B6。
蒜苗除具有醒脾气，消积食，杀菌，抑菌，防流感，肠炎，明显的降血脂，预防冠心病，动脉硬化，脑血栓，护肝，防癌的作用。紫菜由于营养价值很高，并含有丰富的微量元素，素有“微量元素宝库”之称，含有维生素A、C、B2、胆碱，以及硒、磷、碘，紫菜所含的维生素A是牛乳的67倍，维生素C是卷心菜的70倍，维生素B2是香菇的9倍，所含的磷元素居藻类之首，每100克紫菜中硒元素的含量是8.43毫克，硒对80多种疾病均有很好的预防、治疗或辅助治疗的效果。
苹果甘凉，具有生津止渴，润肺除烦，健脾益胃，养心益气，润肠止泻，解暑，醒酒，降低血压，胆固醇，增强记忆，预防老年痴呆症，具有强力地消除传染性病毒的作用，防癌、防铅中毒。苹果含维生素A、B、C、不饱和脂肪酸及钙、磷、铁、钾、锌、钠等苹果是心血管的保护神，心脏病患者的健康元素，还能改善呼吸系统和肺的功能。
西瓜为瓜中之王，几乎含有人体所需的各种营养成分，是一种最富有营养，最纯净，最安全的天然绿色食品。西瓜能治肾炎，降低血压，利尿并消除肾脏炎症。治疗性功能障碍，对心脑血管有保护作用，西瓜含有维生素A、B、C以及钙、磷、铁等矿物质。
酵素酶原液真空干燥混合纳米粉，制备方法：
将上述质量份的瓜果蔬菜类新鲜物料洗净切碎，装在大缸或不漏水的瓷器木制器皿内，用一层盖一层等量的白糖、葡萄糖、果糖或戊糖与腌咸菜那样，仅是不用食盐，改用白糖等糖类进行腌制，器皿口垫纸覆盖执紧密封，置温度20℃以上而无光线直接照射的地方3天，便会生出白霉浮在上面，这时要捞出白霉，继续放置一段时间，直至上述瓜果蔬菜完全腌透时，压榨过滤，高速离心沉淀，取上清液，这就是酵素原液或称酵素酶原液再用超低温冷冻真空干燥超细微纳米技术处理装置制成纳米粉备用。
酵素是一种蛋白质，不具有生命，也无法繁殖，但却是一切生命的基础，生物若无酵素却无法生存，目前为止人体内已发现酵素多达1000种以上，酵素又称为具有生物活性的酶，它关系着人的生命现象，人体若无酵素酒无法生存，酵素正常运行，才能使人体内的机能正常活动，人体缺少酵素就会生病，人体若无酵素生命就会立即终止，因此酵素是健康的源泉，也是生命的源泉，酵素具有排毒解毒，提高免疫功能，它是生物体内各种反应的媒介，酵素补充剂能够在短时间内增加7倍的巨噬细胞和3倍的杀伤细胞酵素广泛地存在于动植物食物中一旦加热到48℃以上时这些酵素就会被破坏。科学研究表明酵素进入人体30分钟后，就开始发生作用，分解老化细胞，制造新生细胞，在高倍显微镜下我们可以发现，组织中活细胞数量有大幅度增加，而且老龄化细胞也渐趋于饱满，同时酵素开始分解血液中的废物，使血液保持弱碱性，促进血液循环，人体中的氨基酸会产生阿摩尼亚等毒性有害物质，而体内的酵素还能将这些有害物质转变成低毒性的尿液排出体外，酵素还有消炎杀菌、防感染的防御能力，有效地抵抗异物侵袭。
微量元素可以使人延缓衰老，有关人类衰老机理的学说很多，概况起来，有遗传和非遗传因素两类，其中许多环节，微量元素起着重要的作用。目前研究大多几种在锌、锰、铜、镉、铁、铬、硒、铅、铝和氟等10种微量元素。
补锌和锰可以延缓衰老。衰老与细胞的增殖和分化减缓有关。细胞增殖的先决条件是DNA复制需要DNA聚合酶的催化才能完成。细胞的分化必须有RNA的转录并合成蛋白质才能完成，而RNA的转录必须有RNA聚合酶的催化，以上两种聚合都必须有锌和锰的激活才具有较高的催化性。因此，老年人如缺锌和缺锰，就会加快衰老的进程。适量补充锌和锰，可以延缓衰老。
衰老与抗氧化作用减弱有关。在抗氧化作用中，超氧化物歧化酶(SOD)起到很重要的作用，它能将超氧化物转变为无氧化作用的物质，从而达到抗氧化作用。SOD的组分中必须有锰的参与，否则SOD就没有活性，适量补充锌和锰，可以延缓衰老。老年人的甲状腺功能减退，头发变白，骨质疏松，智力减退，动脉粥样硬化，味觉、嗅觉和视觉减退，免疫功能低下等，都与缺锌和缺锰有关，适量补充锌和锰，可以延缓这些老年症状的发生。
补铜排镉可以延缓衰老。胶原是人体内含量最多的蛋白质，占人体蛋白总量的1/4-1/3，是结缔组织的主要组分。胶原纤维遍布全身各处，不仅是疏松结缔组织及肌腱的主要组分，也是骨、牙、软骨的结构基础。铜是胶原酶的激活剂，是胶原代谢的重要因素，缺铜时，胶原代谢容易发生异常，故易致牙齿脱落、骨质疏松、骨折及肌腱劳损。老年人缺铜时，还可致细胞色素氧化酶减少、活性下降，运动失调，步履不稳，思维迟钝，铁运输障碍，引起缺铁性贫血。
镉是对人体有害的微量元素，摄入镉后，可致小血管平滑肌收缩或痉挛，从而发生高血压。因此，老年人应适量补充铜和排除镉，可以预防缺铁性贫血。
补充铁和铬可以延缓衰老。老年人发生贫血的主要原因是红血球摄取铁的能力降低，铁的利用减少。红血球摄取铁，正常人是91.2％，正常老年人则为66％。另一方面，老年人体内贮铁过多，可致胰腺纤维化及功能不良，铁过多还干扰体内铬的运输，胰腺因而缺铬，干扰胰岛素生物活性，故易致糖尿病。铁过多致色素代谢紊乱，皮肤呈棕黑色。
铬通过形成葡萄糖耐量因子协助胰岛素发挥生物活性，这个因子能调节胰岛素与其在细胞膜上的受体的氢硫基(-SH)形成二硫键(-S-S-)，促使胰岛素发挥最大的生物效应。老年人缺铬易患糖尿病，老年人应适量补充铁和铬，可以延缓衰老。
补硒锗排铅汞砷可以延缓衰老。抗氧化作用较差且不能及时消除自由基是人类衰老的一个原因，这也是老年人多发病如心血管疾病、神经系统疾病等的分子病理学基础。硒是谷胱甘肽过氧化酶(GSH-Px)的必需组分，它能催化有害的氧化物(-ROOH)还原成为无毒的羟基化合物，从而保护所有的生物膜。
老年人如缺硒，则清除自由基作用减弱，而且对细胞膜上的Na-K-ATP酶与5-苷-核苷酸酶的活性明显下降，能引起Na、K、Ca离子出入细胞异常及核苷酸代谢紊乱，造成严重后果。
铅中毒的分子病理学机制是因为铅及钙两个离子的电荷和离子的直径相同，致使线粒体不能分辨，从而以同样的方式进行代谢，铅和钙一样容易进入线粒体内，但钙很容易排出，而铅则不易排出，铅与线粒体内磷酸盐及硫化物牢固地结合起来(其结合力比钙高100万倍)，不断沉积于线粒体中，导致线粒体不断膨胀，供能机构受到破坏，甚至细胞因缺能而致死亡，死亡后细胞释出的铅，又由血液进入其它细胞，加速在线粒体内沉积，形成恶性循环，细胞破坏严重。因此，老年人应适量补充硒，严防过多地摄入铅，从而延缓衰老。
补氟排铅可以延缓衰老。阿尔茨海默病，人们长期歧视性称之为老年痴呆症，该病发病率较高，约为5％-7％，如将轻型病例计算在内，则发病率达10％，70-80岁发病率可达12％-15％。阿尔茨海默病患者大脑铝水平明显升高，约为正常人的10-30倍。铝集聚与脑细胞核染色体内，从而使DNA发生损伤，很少量的铝可能产生严重的神经性和行为退化。
氟关系到人体骨骼的形成和结构，老年人缺氟则能影响钙和磷的利用，可致骨质疏松，发生骨折。氟有刺激新骨生长的作用，氟化物结合于磷灰石结晶内，则不易被破骨细胞溶解，从而使骨形成增加。因此，老年人应尽可能减少铝的摄入，适当补充氟，从而延缓衰老。
下面结合实施例子对本发明进一步阐明：
具体实施方法：
实施例1：
(1)强化微量元素补充剂，其特征是：由下列单质态质量份配比组成％
(2)强化维生素族补充剂，其特征是：由下列质量成份配比组成％
维生素族是由水溶性维生素、脂溶性维生素组成；
水溶性维生素
脂溶性维生素
水溶性维生素95％+脂溶性维生素5％＝维生素族100％；
(3)强化补充微量元素天然绿色食物，其特征是：由下列质量份配比组成％
①补锌锰天然食物
含锌：牡蛎干每1000g含1210mg锌，田螺、海参占82mg，黄鳝140mg，菇类含锌80-140mg，含铁1885mg；
含锰：坚果、茶叶含锰每1000g含660-780mg，鸭蛋黄含2400mg，鸡蛋黄含1100mg；
②补铜排镉的天然食物
③补铁铬延缓衰老天然食物
黑木耳、干蘑菇每1000g含铁1850mg铁元素，海带1500mg，海参含铬21-38mg；
④补硒锗排铅增氧天然食物
胡桃每1000g含硒29.6mg，树菠萝27.9mg，灵芝、人参含硒、锗元素排铅、汞、碘、镉等重金属元素和有毒物质，增氧排废，抗氧化清除自由基；
⑤补氟排铅延缓衰老的天然食物
绿茶每1000g含氟89.4-220.4mg，红茶48.4±14.7mg；
(4)强化补充降压降脂益寿中药流浸膏，其特征是：由下列相同质量份配比组成％
灵芝、何首乌、枸杞子、茯苓、冬虫夏草、绞股蓝、红景天、黄芪、黄精、杜仲、当归、酸枣仁、蒲公英、松花粉；
功效：降血压、降血脂、调节免疫功能、延缓衰老；
应用：高血压、高血脂等中老年衰弱症；
实验研究：
①果蝇寿命试验：能显著延长雌雄果蝇平均寿命和最高寿命(♀P＜0.05，♂＜0.01)；
②小鼠试验：能使血清SOD活性显著升高(P＜0.01)，MDA含量显著降低(P＜0.01)；
③小鼠迟发变态反应试验：服药组与对照组比，足趾肿胀度均数有显著变异(P＜0.01)；血清溶血素试验，抗体积数有显著提高(P＜0.01)；腹腔巨噬细胞吞噬鸡红细胞试验，吞噬百分率，吞噬指数与对照组比，显著提高(P＜0.01)；NK细胞活性无显著差异(P＞0.05)，证明有免疫调节作用。
以上各组分别用常规二氧化碳萃取或用60％乙醇提取的方法提取，滤液经薄膜蒸发、回收乙醇，并浓缩成1∶1，即每毫升含源生药1g，相对密度为1.03-1.05的流浸膏备用。用时将流浸膏真空干燥研细与其他物料共同混合，将其混合物料再用纳米粒径超细微化通用装置将物料的大分子进行破碎、乳化、均质、分散，从而粒化成纳米级粒径的小分子过1800-2200目筛，中心粒径为0.1-5μm，因为药物的吸收常受药物在吸收部位溶出速度的支配，而减小粒径，可以增大在暴露在介质中的表面积，而促进溶解，进而提高药物的吸收度和利用率，增大了药效和治疗效果。
(5)强化补充天然食物西瓜类植物酵素干燥纳米粉，其特征是：由下列质量份配比组成％
一种天然食物元素强化剂酵素西瓜粉，是由强化微量元素补充剂混合纳米粉、强化维生素族补充剂混合纳米粉、强化补充微量元素天然绿色食物①号纳米粉、强化补充降压、降脂益寿中药流浸膏干燥纳米粉、强化补充天然食物西瓜类提取物植物酵素干燥纳米粉组成，其特征是：由下列质量份配比组成％
实施例2：一种天然食物元素强化剂酵素西瓜粉，是由强化微量元素补充剂混合纳米粉、强化维生素族补充剂混合纳米粉、强化补充微量元素天然绿色食物②号纳米粉、强化补充降压、降脂益寿中药流浸膏干燥纳米粉、强化补充天然食物西瓜类提取物植物酵素干燥纳米粉组成，其特征是：由下列质量份配比组成％
实施例3：一种天然食物元素强化剂酵素西瓜粉，是由强化微量元素补充剂混合纳米粉、强化维生素族补充剂混合纳米粉、强化补充微量元素天然绿色食物③号纳米粉、强化补充降压、降脂益寿中药流浸膏干燥纳米粉、强化补充天然食物西瓜类提取物植物酵素干燥纳米粉组成，其特征是：由下列质量份配比组成％
实施例4：一种天然食物元素强化剂酵素西瓜粉，是由强化微量元素补充剂混合纳米粉、强化维生素族补充剂混合纳米粉、强化补充微量元素天然绿色食物④号纳米粉、强化补充降压、降脂益寿中药流浸膏干燥纳米粉、强化补充天然食物西瓜类提取物植物酵素干燥纳米粉组成，其特征是：由下列质量份配比组成％
实施例5：一种天然食物元素强化剂酵素西瓜粉，是由强化微量元素补充剂混合纳米粉、强化维生素族补充剂混合纳米粉、强化补充微量元素天然绿色食物⑤号纳米粉、强化补充降压、降脂益寿中药流浸膏干燥纳米粉、强化补充天然食物西瓜类提取物植物酵素干燥纳米粉组成，其特征是：由下列质量份配比组成％
Claims (1)
1.一种天然食物元素强化剂酵素西瓜粉，其特征是：由下列质量份配比组成％
(1)强化微量元素补充剂，其特征是：由下列单质态质量份配比组成％
(2)强化维生素族补充剂，其特征是：由下列质量成份配比组成％
维生素族是由水溶性维生素、脂溶性维生素组成；
水溶性维生素
脂溶性维生素
水溶性维生素95％+脂溶性维生素5％＝维生素族100％；
(3)强化补充微量元素天然绿色食物，其特征是：由下列质量份配比组成％
①补锌锰天然食物
含锌：牡蛎干每1000g含1210mg锌，田螺、海参占82mg，黄鳝140mg，菇类含锌80-140mg，含铁1885mg；
含锰：坚果、茶叶含锰每1000g含660-780mg，鸭蛋黄含2400mg，鸡蛋黄含1100mg；
②补铜排镉的天然食物
③补铁铬延缓衰老天然食物
黑木耳、干蘑菇每1000g含铁1850mg铁元素，海带1500mg，海参含铬21-38mg；
④补硒锗排铅增氧天然食物
胡桃每1000g含硒29.6mg，树菠萝27.9mg，灵芝、人参含硒、锗元素排铅、汞、碘、镉等重金属元素和有毒物质，增氧排废，抗氧化清除自由基；
⑤补氟排铅延缓衰老的天然食物
绿茶每1000g含氟89.4-220.4mg，红茶48.4±14.7mg；
(4)强化补充降压降脂益寿中药流浸膏，其特征是：由下列相同质量份配比组成％
灵芝、何首乌、枸杞子、茯苓、冬虫夏草、绞股蓝、红景天、黄芪、黄精、杜仲、当归、酸枣仁、蒲公英、松花粉；
(5)强化补充天然食物西瓜类植物酵素干燥纳米粉，其特征是：由下列质量份配比组成％
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410112395.4A CN103892280A (zh) | 2014-03-22 | 2014-03-22 | 天然食物元素强化剂酵素西瓜粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410112395.4A CN103892280A (zh) | 2014-03-22 | 2014-03-22 | 天然食物元素强化剂酵素西瓜粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103892280A true CN103892280A (zh) | 2014-07-02 |
Family
ID=50984109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410112395.4A Pending CN103892280A (zh) | 2014-03-22 | 2014-03-22 | 天然食物元素强化剂酵素西瓜粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103892280A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040100896A1 (en) * | 2002-08-19 | 2004-05-27 | Vayanos Alkinoos Hector | De-boosting in a communications environment |
| CN101366530A (zh) * | 2008-09-27 | 2009-02-18 | 沈阳麦金利食品制造有限公司 | 一种复合酵素的制作工艺及产品 |
| CN102731188A (zh) * | 2012-06-28 | 2012-10-17 | 黑龙江省京福龙农牧科技开发有限公司 | 一种植物精华酵素及其制备方法 |
| CN103349779A (zh) * | 2013-05-14 | 2013-10-16 | 成进学 | 防治心脑血管疾病的元素维生素蔬菜酮聚酶保健胶丸 |
-
2014
- 2014-03-22 CN CN201410112395.4A patent/CN103892280A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040100896A1 (en) * | 2002-08-19 | 2004-05-27 | Vayanos Alkinoos Hector | De-boosting in a communications environment |
| CN101366530A (zh) * | 2008-09-27 | 2009-02-18 | 沈阳麦金利食品制造有限公司 | 一种复合酵素的制作工艺及产品 |
| CN102731188A (zh) * | 2012-06-28 | 2012-10-17 | 黑龙江省京福龙农牧科技开发有限公司 | 一种植物精华酵素及其制备方法 |
| CN103349779A (zh) * | 2013-05-14 | 2013-10-16 | 成进学 | 防治心脑血管疾病的元素维生素蔬菜酮聚酶保健胶丸 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103404921B (zh) | 一种果蔬酵素组合物及其制备方法 | |
| CN102077936A (zh) | 一种糖尿病患者专用的海洋特膳食品 | |
| CN106212046A (zh) | 一种肉灵芝培育方法及加工肉灵芝水的方法 | |
| CN1903232A (zh) | 一种辣木粉营养品及其制备方法 | |
| CN101642176B (zh) | 一种缓解神经衰弱的酸枣蜂蜜保健饮料的制作方法 | |
| KR20130029098A (ko) | 누에와 뽕나무잎과 상지(桑枝)를 이용한 이온미네랄 제조방법 및 이에 의해 제조 된 건강음료 | |
| CN104055180A (zh) | 高硒锗酵素酶饮料 | |
| CN105495414A (zh) | 一种高丽红参芝麻抗衰老功能食品的制备方法 | |
| CN103142765A (zh) | 富硒锗纳米元素与维生素全营养的灵芝蛇药酒 | |
| CN103262980A (zh) | 富硒锗铬元素维生素螺旋藻保健米粉 | |
| CN105410930A (zh) | 一种具有减肥瘦身、均衡营养功能的保健品及其制备方法 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| RU2283124C1 (ru) | Биологически активный препарат на основе морского растительного сырья | |
| CN103349779A (zh) | 防治心脑血管疾病的元素维生素蔬菜酮聚酶保健胶丸 | |
| CN108066384A (zh) | 一种具有增强免疫力功能的中药制剂及其制备方法 | |
| CN102754834A (zh) | 调节情绪舒缓压力的生物合剂及其制备方法 | |
| CN103877002A (zh) | 酵素酶蛋白排毒祛斑霜 | |
| CN104738749A (zh) | 一种纯天然营养免疫保健果汁的配制方法 | |
| CN103932941A (zh) | 营养元素抗衰护肤液 | |
| CN100392058C (zh) | 含纳米sod的果酒及其制备方法 | |
| CN103385465A (zh) | 天然绿色元素方便米饭 | |
| CN103892280A (zh) | 天然食物元素强化剂酵素西瓜粉 | |
| CN106942433A (zh) | 一种黑莓茶的制备方法 | |
| CN103897957A (zh) | 富硒锗灵芝酵素酒 | |
| CN103355671A (zh) | 增加细胞基因繁殖倍数的纳米元素益寿胶囊 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 226000 Nantong City, Gangzha District, Qin Qin street, the village of the four groups of the temple of the group of eight in the District of Jiangsu Applicant after: NANTONG SNAKEBITE THERAPY INSTITUTE Address before: 226006 Jiangsu, Nantong, the Bund District, building 501, room 18 Applicant before: NANTONG SNAKEBITE THERAPY INSTITUTE |
|
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140702 |